Assessment Of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years Of Age For Mfld Development

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Assessment Of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years Of Age For Mfld Development trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

UnknownNot Applicable

NCT06157125

Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN

Fatty liver disease is a global health concern with a prevalence of about 25% amongst United States. Its increased prevalence is attributed to increase in patie…

Egypt100 participantsStarted 2024-06